Practical Aspects and Considerations When Switching Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections
Author:
Affiliation:
1. Division of Endocrinology and Diabetes, University of Miami Miller School of Medicine, Miami, Florida.
2. Patient Education Center, Diabetes Research Institute, University of Miami, Miami, Florida.
Publisher
Mary Ann Liebert Inc
Subject
Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.liebertpub.com/doi/pdf/10.1089/dia.2009.0184
Reference42 articles.
1. A Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients With Long-Standing Poor Glycemic Control
2. Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII
3. Insulin Pump Therapy
4. How Diabetes Specialists Treat Their Own Diabetes: Findings From a Study of the AADE and ADA Membership
5. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of insulin dose changes in pediatric patients with type 1 diabetes mellitus starting on continuous subcutaneous insulin infusion;Journal of Clinical & Translational Endocrinology;2024-09
2. Comparison of Network Meta-Analyses Investigating Efficacy of Diabetes Monitoring Systems with Insulin Delivery in Patients with Type-1 Diabetes, Using Non-Randomized Studies, Randomized-Controlled Trials, or Both as Evidence;2024
3. Prevalence of and Reasons for Discontinuation of Continuous Subcutaneous Insulin Infusion in People with Type 1 Diabetes: A Systematic Review;Diabetes Technology & Therapeutics;2023-08-01
4. Correlation in Dose-Response to Rapid- and Long-Acting Insulin for People with Type 1 Diabetes;2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC);2022-07-11
5. Glucose Response to Fast- and Long-Acting Insulin in People with Type 2 Diabetes;IFAC-PapersOnLine;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3